Efficacy of beta blocker for the patients with acute coronary syndrome undergoing primary percutaneous coronary intervention

Efficacy of beta blocker for the patients with acute coronary syndrome undergoing primary percutaneous coronary intervention - Efficacy of beta blocker for the patients with acute coronary syndrome undergoing primary percutaneous coronary intervention

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000010696

Enrollment

Registered

2013-05-13

Start date

2013-05-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute coronary syndrome

Interventions

treatment with landiolol conventional treatment without landiolol

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: acute coronary syndrome

Exclusion criteria

Exclusion criteria: systolic blood pressure of less than 80mmHg or heart rate of less than 50 beats/min 2-AV block or 3-AV block history of side effects of beta blocker

Design outcomes

Primary

Measure	Time frame
cardiac function incidence of arrhythmias HR,blood pressure ,cardial index ,PA	—

Secondary

Measure	Time frame
CK,BNP mortarity complication	—

Countries

Japan

Contacts

Public ContactSakaguchi Teruhiro

Tosei General Hospital Department of Cardiology

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026